Int J Stomatol

Int J Stomatol ›› 2020, Vol. 47 ›› Issue (5): 515-521.doi: 10.7518/gjkq.2020080

• Oral Microecology • Previous Articles     Next Articles

Progress on the application of probiotics in the management of periodontal diseases

Jia Leming1(),Jia Xiaoyue2,Yang Ran2,Zhou Xuedong1,Xu Xin1()   

  1. 1.State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
    2.State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Pediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2020-01-05 Revised:2020-04-02 Online:2020-09-01 Published:2020-09-16
  • Contact: Xin Xu E-mail:leming401@163.com;xu@scu.edu.cn
  • Supported by:
    National Natural Science Foundation of China(81870754);National Natural Science Foundation of China(81800989);Program Funded by Science and Technology Department of Sichuan Province(2018SZ0121)

RichHTML

32

PDF (PC)

325

Abstract:

Periodontal diseases, which can seriously damage the structures that surround the teeth, including gums, perio-dontal ligament, and alveolar bone, are the major causes of tooth loss among adults. Approximately 80%-90% of adults in China are suffering from different degrees of periodontal diseases. The etiology of periodontal diseases is complicated, but periodontal micro dysbiosis and abnormal host immune response are recognized as the important causes of these diseases. The basic treatment of these diseases includes the mechanical removal of calculus and plaque and systemic and topical medications. Several drugs that modulate periodontal microbial ecology and immune abnormality have emerged because of the re-colonization of oral pathogens and the incidence of antibacterial resistance. Probiotics have been used to address intestinal microbial dysbiosis, and their application in the treatment of oral infectious diseases has also been suggested. This article reviewed the progress on the research and application of probiotics in the treatment of periodontal diseases to provide a new paradigm for the ecological management of these diseases.

Key words: periodontal diseases, probiotics, oral microecology, periodontal microecology

CLC Number: 

  • R781.4

TrendMD: 

Tab 1

Classification of probiotics for use in humans approved by National Health Commission of the People’s Republic of China"

菌属 菌种名称
乳杆菌属 德氏乳杆菌（Lactobacillus delbrueckii）、短乳杆菌（Latobacillus brevis）、嗜酸乳杆菌（Lactobacillus acidophilus）、保加
利亚乳杆菌（Lactobacillus bulgaricus）、干酪乳杆菌（Lactobacillus casei）、发酵乳杆菌（Lactobacillus fermentium）、植
物乳杆菌（Lactobacillus plantarum）、鼠李糖乳杆菌（Lactobacillus rhamnosus）等
双歧杆菌属 青春双歧杆菌（Bifidobacterium adolescentis）、长双歧杆菌（Bifidobacterium longum）、短双歧杆菌（Bifidobacterium
breve）、嗜热双歧杆菌（Bifidobacterium thermophilum）、乳双歧杆菌（Bifidobacterium lactis）等
肠球菌属 粪肠球菌（Enterococcus faecalis）、屎肠球菌（Enterococcus faecium）等
链球菌属 嗜热链球菌（Streptococcus thermophilus）
芽孢杆菌属 枯草芽孢杆菌（Bacillus subtilis）、蜡样芽孢杆菌（Bacillus cereus）、地衣芽孢杆菌（Bacillus licheniformis）、凝结芽孢杆
菌（Bacillus coagulans）
梭菌属 酪酸梭菌（Clostridium butyricum）
酵母菌属 布拉酵母菌（Saccharomyces boulardii）

Tab 2

Totally or partially proven probiotic activity and mode of action on oral infectious diseases"

菌种或菌属名称 作用机制或应用领域
唾液链球菌K12 拮抗口腔病原菌[19]
罗伊氏乳杆菌 抑制口腔病原菌黏附[20]
（Lactobacillus reuteri）
唾液链球菌M18 作用于口腔黏膜上皮[21]
嗜酸乳杆菌LA-5 阻碍生物膜形成[21]
干酪乳杆菌LC-11 阻碍致龋生物膜形成[22,23]
副干酪乳杆菌 龋病治疗[23]
乳杆菌属 牙周病治疗[23]
双歧杆菌属 牙龈炎治疗[24]
鼠李糖乳杆菌 免疫调节[25]
乳双歧杆菌 提高对口腔感染的抵抗力[26]
[1] Krishnan K, Chen T, Paster BJ. A practical guide to the oral microbiome and its relation to health and disease[J]. Oral Dis, 2017,23(3):276-286.
doi: 10.1111/odi.12509 pmid: 27219464
[2] Leys EJ, Griffen AL, Beall C, et al. Isolation, classi-fication, and definition of oral microorganisms[M]. Washington: ASM Press, 2014: 71-74.
[3] 周学东, 施文元. 口腔微生态学[M]. 北京: 人民卫生出版社, 2013: 109-113.
Zhou XD, Shi WY. Oral microecology[M]. Beijing: People’s Medical Publishing House, 2013: 109-113.
[4] Theilade E. The non-specific theory in microbial etiology of inflammatory periodontal diseases[J]. J Clin Periodontol, 1986,13(10):905-911.
doi: 10.1111/j.1600-051x.1986.tb01425.x pmid: 3540019
[5] Marsh PD. Microbial ecology of dental plaque and its significance in health and disease[J]. Adv Dent Res, 1994,8(2):263-271.
doi: 10.1177/08959374940080022001 pmid: 7865085
[6] Pérez-Chaparro PJ, Gonçalves C, Figueiredo LC, et al. Newly identified pathogens associated with per-iodontitis: a systematic review[J]. J Dent Res, 2014,93(9):846-858.
doi: 10.1177/0022034514542468
[7] Richards AM, Abu Kwaik Y, Lamont RJ. Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity[J]. Mol Oral Microbiol, 2015,30(1):2-15.
doi: 10.1111/omi.12072 pmid: 25052812
[8] Albandar JM. Aggressive periodontitis: case defini-tion and diagnostic criteria[J]. Periodontol 2000, 2014,65(1):13-26.
doi: 10.1111/prd.12014
[9] Könönen E, Müller HP. Microbiology of aggressive periodontitis[J]. Periodontol 2000, 2014,65(1):46-78.
doi: 10.1111/prd.12016
[10] Vartoukian SR, Palmer RM, Wade WG. Diversity and morphology of members of the phylum “syner-gistetes” in periodontal health and disease[J]. Appl Environ Microbiol, 2009,75(11):3777-3786.
doi: 10.1128/AEM.02763-08 pmid: 19346352
[11] Lu HY, Zhao YB, Feng XH, et al. Microbiome in maintained periodontitis and its shift over a single maintenance interval of 3 months[J]. J Clin Perio-dontol, 2019,46(11):1094-1104.
[12] Kornman KS. Mapping the pathogenesis of perio-dontitis: a new look[J]. J Periodontol, 2008,79(8 Suppl):1560-1568.
doi: 10.1902/jop.2008.080213 pmid: 18673011
[13] Costalonga M, Herzberg MC. The oral microbiome and the immunobiology of periodontal disease and caries[J]. Immunol Lett, 2014,162(2 Pt A):22-38.
doi: 10.1016/j.imlet.2014.08.017 pmid: 25447398
[14] 王晖, 康迪, 周学东, 等. 微生态调节技术在感染性疾病预防中的应用[J]. 华西口腔医学杂志, 2018,36(5):564-567.
Wang H, Kang D, Zhou XD , et al. Prevention of in- fectious diseases through microecology modulation techniques[J]. West China J Stomatol, 2018,36(5):564-567.
[15] 李兰娟. 医学微生态学[M]. 北京: 人民卫生出版社, 2014: 16, 282-285.
Li LJ. Medical microecology[M]. Beijing: People’s Medical Publishing House, 2014: 16, 282-285.
[16] Seminario-Amez M, López-López J, Estrugo-Devesa A, et al. Probiotics and oral health: a systematic re- view[J]. Med Oral Patol Oral Cir Bucal, 2017,22(3):e282-e288.
doi: 10.4317/medoral.21494 pmid: 28390121
[17] 李凤琴. 食品微生物菌种安全性评估研究进展[J]. 中国食品卫生杂志, 2018,30(6):667-672.
Li FQ . Progress on safety assessment of microbial food cultures[J]. Chin J Food Hyg, 2018,30(6):667-672.
[18] Joint FAO/WHO Expert Consultation. Health and nutritional properties of probiotics in food including powder milk with live latic acid bacteria[R]. Córdoba: FAO/ WHO, 2001.
[19] Masdea L, Kulik EM, Hauser-Gerspach I, et al. Anti-microbial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour[J]. Arch Oral Biol, 2012,57(8):1041-1047.
doi: 10.1016/j.archoralbio.2012.02.011
[20] Jørgensen MR, Kragelund C, Jensen PØ, et al. Pro-biotic Lactobacillus reuteri has antifungal effects on oral Candida species in vitro[J]. J Oral Microbiol, 2017,9(1):1274582.
doi: 10.1080/20002297.2016.1274582 pmid: 28326154
[21] Manning J, Dunne EM, Wescombe PA, et al. Inves-tigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cells[J]. BMC Microbiol, 2016,16(1):225.
pmid: 27681377
[22] Chuang LC, Huang CS, Ou-Yang LW, et al. Probiotic Lactobacillus paracasei effect on cariogenic bacterial flora[J]. Clin Oral Investig, 2011,15(4):471-476.
pmid: 20502929
[23] Schwendicke F, Dörfer C, Kneist S, et al. Cariogenic effects of probiotic Lactobacillus rhamnosus GG in a dental biofilm model[J]. Caries Res, 2014,48(3):186-192.
doi: 10.1159/000355907
[24] Invernici MM, Salvador SL, Silva PHF, et al. Effects of Bifidobacterium probiotic on the treatment of chronic periodontitis: a randomized clinical trial[J]. J Clin Periodontol, 2018,45(10):1198-1210.
pmid: 30076613
[25] Fong FL, Shah NP, Kirjavainen P, et al. Mechanism of action of probiotic bacteria on intestinal and syste-mic immunities and antigen-presenting cells[J]. Int Rev Immunol, 2016,35(3):179-188.
pmid: 26606641
[26] Oliveira LF, Salvador SL, Silva PH, et al. Benefits of Bifidobacterium animalis subsp. lactis probiotic in experimental periodontitis[J]. J Periodontol, 2017,88(2):197-208.
doi: 10.1902/jop.2016.160217 pmid: 27660886
[27] Teughels W, Durukan A, Ozcelik O, et al. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study[J]. J Clin Pe-riodontol, 2013,40(11):1025-1035.
[28] Shah MP, Gujjari SK, Chandrasekhar VS. Evaluation of the effect of probiotic (inersan®) alone, combina-tion of probiotic with doxycycline and doxycycline alone on aggressive periodontitis—a clinical and microbiological study [J]. J Clin Diagn Res, 2013,7(3):595-600.
pmid: 23634432
[29] Riccia DN, Bizzini F, Perilli MG, et al. Anti-inflam-matory effects of Lactobacillus brevis (CD2) on pe-riodontal disease[J]. Oral Dis, 2007,13(4):376-385.
pmid: 17577323
[30] Vicario M, Santos A, Violant D, et al. Clinical changes in periodontal subjects with the probiotic Lactoba-cillus reuteri prodentis: a preliminary randomized clinical trial[J]. Acta Odontol Scand, 2013,71(3/4):813-819.
doi: 10.3109/00016357.2012.734404
[31] Shimauchi H, Mayanagi G, Nakaya S, et al. Im-provement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study[J]. J Clin Periodontol, 2008,35(10):897-905.
doi: 10.1111/j.1600-051X.2008.01306.x pmid: 18727656
[32] Lauritano D, Carinci F, Palmieri A, et al. Reuterinos® as adjuvant for peri-implant treatment: a pilot study [J]. Int J Immunopathol Pharmacol, 2019,33:2058738419827745.
pmid: 30791748
[33] Mayanagi G, Kimura M, Nakaya S, et al. Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial[J]. J Clin Periodontol, 2009,36(6):506-513.
pmid: 19453574
[34] Kõll-Klais P, Mändar R, Leibur E, et al. Oral lacto-bacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity[J]. Oral Microbiol Immunol, 2005,20(6):354-361.
doi: 10.1111/j.1399-302X.2005.00239.x pmid: 16238595
[35] Krasse P, Carlsson B, Dahl C, et al. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri[J]. Swed Dent J, 2006,30(2):55-60.
pmid: 16878680
[36] Schmitter T, Fiebich BL, Fischer JT, et al. Ex vivo anti-inflammatory effects of probiotics for perio-dontal health[J]. J Oral Microbiol, 2018,10(1):1502027.
pmid: 30057719
[37] Hallström H, Lindgren S, Yucel-Lindberg T, et al. Effect of probiotic lozenges on inflammatory reac-tions and oral biofilm during experimental gingivitis[J]. Acta Odontol Scand, 2013,71(3/4):828-833.
doi: 10.3109/00016357.2012.734406
[38] Twetman S, Derawi B, Keller M, et al. Short-term effect of chewing gums containing probiotic Lacto-bacillus reuteri on the levels of inflammatory me-diators in gingival crevicular fluid[J]. Acta Odontol Scand, 2009,67(1):19-24.
doi: 10.1080/00016350802516170 pmid: 18985460
[39] İnce G, Gürsoy H, İpçi ŞD, et al. Clinical and bio-chemical evaluation of lozenges containing Lacto-bacillus reuteri as an adjunct to non-surgical perio-dontal therapy in chronic periodontitis[J]. J Perio-dontol, 2015,86(6):746-754.
[40] Morales A, Carvajal P, Silva N, et al. Clinical effects of Lactobacillus rhamnosus in non-surgical treatment of chronic periodontitis: a randomized placebo-con-trolled trial with 1-year follow-up[J]. J Periodontol, 2016,87(8):944-952.
pmid: 26944407
[41] Tyagi AM, Yu MC, Darby TM, et al. The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression[J]. Immunity, 2018, 49(6): 1116- 1131.e7.
pmid: 30446387
[42] Sima C, van Dyke TE. Therapeutic targets for mana-gement of periodontitis and diabetes[J]. Curr Pharm Des, 2016,22(15):2216-2237.
doi: 10.2174/1381612822666160216150338 pmid: 26881443
[43] Penoni DC, Fidalgo TK, Torres SR, et al. Bone density and clinical periodontal attachment in postmeno-pausal women: a systematic review and meta-analysis[J]. J Dent Res, 2017,96(3):261-269.
pmid: 28048966
[44] 张灼阳, 刘畅, 郭晓奎. 益生菌的安全性[J]. 微生物学报, 2008,48(2):257-261.
Zhang ZY, Liu C, Guo XK . Safety of probiotics—a review[J]. Acta Microbiol Sin, 2008,48(2):257-261.
[45] 郭淑娟, 刘倩, 丁一. 牙周病和植体周病国际新分类简介[J]. 国际口腔医学杂志, 2019,46(2):125-134.
Guo SJ, Liu Q, Ding Y . A brief introduction of the new classification scheme for periodontal and peri-implant diseases and conditions[J]. Int J Stomatol, 2019,46(2):125-134.
[1] Cheng Yifan,Qin Xu,Jiang Ming,Zhu Guang-xun.. Research progress on innate lymphoid cells in periodontal diseases [J]. Int J Stomatol, 2023, 50(1): 32-36.
[2] Chen Liang,Ding Yi,Meng Shu. Research progress of host modulation therapy in the treatment of periodontal diseases [J]. Int J Stomatol, 2020, 47(6): 706-710.
[3] Liu Lin,Zhou Jieyu,Wu Yafei,Zhao Lei. Application of probiotic ecological regulation in prevention and treatment of periodontal diseases [J]. Int J Stomatol, 2020, 47(2): 131-137.
[4] Chen Yanyan,Peng Xian,Zhou Xuedong,Cheng Lei. Application of quantitative light-induced fluorescence in the clinical treatment of caries and periodontal diseases [J]. Int J Stomatol, 2019, 46(6): 699-704.
[5] Wang Zhiqiang, Ma Lijuan, Zhou Haijing, Yang Lan, Nie Hongbing, Xue Long. Research progress on antitumor effect and mechanism of probiotics [J]. Inter J Stomatol, 2017, 44(6): 636-641.
[6] Liu Man1, Meng Yao2, Wu Min1, Ye Lirong1, Zhang Qiang1, Wang Jindong1.. Relationship between periodontal disease and gestational diabetes mellitus [J]. Inter J Stomatol, 2015, 42(1): 19-21.
[7] Li Qian1, Pan Yaping1,2.. Relationship between survivin and oral diseases [J]. Inter J Stomatol, 2013, 40(5): 674-677.
[8] Huang Jing, Liang Jingping.. Research progress on gingival crevicular fluid in patients with diabetes mellitus and periodontal diseases [J]. Inter J Stomatol, 2013, 40(4): 519-522.
[9] Hu Yongxiao, Xie Zhigang. Research progress on periodontal microbiota modification therapy [J]. Inter J Stomatol, 2013, 40(3): 326-329.
[10] Zhang Gang, Tan Yinghui.. Series study of periodontal diseases under highland environment [J]. Inter J Stomatol, 2013, 40(2): 141-143.
[11] Lu Sixian, Wang Qing.. Research progress on Treponema denticola [J]. Inter J Stomatol, 2013, 40(1): 121-124.
[12] Zhao Danfeng, Gong Qimei, Ling Junqi.. Migration inhibitory factor and effect of its on periodontal diseases [J]. Inter J Stomatol, 2012, 39(1): 110-112.
[13] HOU Hai-juan1, ZHANG Jie1, HUANG Ping2.. Research progress on nitric oxide synthase gene polymorphisms on systemic diseases and periodontitis [J]. Inter J Stomatol, 2011, 38(2): 200-203.
[14] SUN Jing-hua, FAN Ming-wen. Bacterial replacement therapy and dental caries [J]. Inter J Stomatol, 2010, 37(02): 170-170～173,177.
[15] MENG Qingwei, ZHAO Er-yang. Detection of denaturing gradient gel electrophoresis in pathogenic bacteria of pe [J]. Inter J Stomatol, 2009, 36(5): 547-549.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[8] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[9] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[10] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .